- GI is exploding with new tech—but how do patients feel about it?
- HHS, CMS form healthcare advisory committee
- NewYork-Presbyterian named in antitrust lawsuit
- Maryland physician to pay $500K+ to settle false claims allegations
- FirstHealth breaks ground on $43M replacement hospital
- Rhode Island oral surgeon launches Congressional campaign
- Johns Hopkins affiliate names new CEO
- 6 things to know about the pharmacy technician workforce
- FDA adds seizure warning to CSL flu vaccine label
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- Why an $8B health system recommitted to its original name
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- Missouri system taps CFO as COO
- HCA moves to block disclosure of physician, patient outcomes post-hospital acquisition
- 6 things to know about CMS’ GLP-1 pilot model: KFF
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- What will surprise ASC leaders about spine in 5 years?
- Why culture is the secret to a high-performing ASC
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- Cardiologist named chief medical officer of biotech company
- St. Luke’s CFO joins RCM company’s advisory board
- 52 DSOs to know: 2026
- 10 hospitals, health systems looking for CFOs
- 10 health system rating downgrades
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- North Star’s restructuring moves forward
- Illinois hospital pauses patient care amid payroll challenges
- What the Best-Performing Revenue Cycles Have in Common
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Medicaid work rules and enrollment losses: 6 notes
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- Adventist Health cuts operating loss in 2025
- ‘Burning the candle from both ends’: New York hospital CFO on rising costs, revenue cuts
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- 21 revenue cycle executive moves in 2026
- North Carolina orthodontic practice opens 7th location
- Virginia hospital boosts workplace safety reporting 245% with 3 strategic shifts
- ADA urges CMS to proceed with adult dental coverage expansion
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Imagen Dental Partners adds Washington practice
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
- Cencora acquiring EyeSouth Partners' retina business for $1.1B
- Aunque tengas seguro dental, la factura puede ser muy alta
- Massive class action seeking RICO penalties against Takeda, Lilly presses forward with SCOTUS order
- A look at how Optum Rx is using AI to address pharmacy fraud, waste and abuse
- Nursing Homes Accused of False Diagnoses To Hide Drug Use
- FDA Approves Higher-Dose Wegovy To Help People Lose More Weight
- Teens Often Pressured To Send Sexual Photos by Someone They Know, Study Finds
- CommonSpirit, Humana reach 3-year national network agreement
- Match Day 2026: Growth in emergency medicine, psychiatry
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- FTC launches multi-bureau Healthcare Task Force to spot 'new priority areas for enforcement'
- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- ¿Qué tan bajo se puede llegar? Las cambiantes guías para el control de la presión arterial
- Rural hospitals could apply for temporary interest-free construction, renovation loans under new bipartisan bill
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
- Insurance Lapses Play Havoc With Diabetes Management, Study Shows
- Psychedelics Aren't Better Than Antidepressants In Treating Depression, Review Concludes
- A Nasal Swab for Alzheimer's? Duke Team Has One in Testing
Department of Health and Human Services Secretary Kennedy reconstituted the Interagency Autism Coordinating Committee (I-ACC) in January with 21 new public members. Now beginning their mandate, they have attacted a great deal of criticism from the establishment:
Kennedy's new US autism panel to examine potential causes
By Leah Douglas and Ahmed Aboulenein - March 5, 2026Summary
- New panel includes vaccine skeptics, raising concerns among autism experts
- Panel could explore controversial vaccine links
- Outside experts warn focus on vaccines may divert funds from other autism research
WASHINGTON, March 5 (Reuters) - A U.S. autism advisory board remade by Health Secretary Robert F. Kennedy Jr. to include vaccine skeptics aims to steer federal research spending toward investigating causes of the condition, as well as other issues like co-occurring medical disorders, according to some new panel members.
Kennedy, a longtime anti-vaccine activist who has suggested the inoculations cause autism, contrary to scientific evidence, reset the Interagency Autism Coordinating Committee in January with 21 new public members. More than a third of the new committee members have also promoted the debunked link between vaccines and autism.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Some autism experts, including former committee members, have said the new members could undermine federal autism research. This week, some former members created their own alternative advisory board, the latest in a series of similar efforts by public health experts concerned about Kennedy's overhaul of federal vaccine policy and what they see as misinformation coming from agencies he oversees.No rigorous studies have found links between autism and vaccines or medications. Autism experts attribute rising rates of the condition largely to more inclusive diagnosis criteria.
The committee, due to first meet on March 19, will provide non-binding guidance to Kennedy on federal autism research priorities, including recommendations on allocating hundreds of millions of dollars in research spending.
Kennedy has promised President Donald Trump he will identify the cause of autism, which most researchers suggest is linked in part to genetics and exposure in utero to pollutants or harmful contaminants. Many of Kennedy's supporters in the Make America Healthy Again movement - some of whom were named to the committee - also believe vaccines can cause autism and advocate for fewer childhood vaccinations.
Committee chair Sylvia Fogel, a psychiatrist and instructor at Harvard Medical School, told Reuters the committee will address gaps in autism research like causal triggers in an effort to better serve people with profound autism and their families.
"Autism is not monolithic. Federal strategy should reflect that complexity rather than flatten it," Fogel said.
Department of Health and Human Services spokesman Andrew Nixon said the new committee is meant to unite a range of voices and that "expanding perspectives on the panel does not change the fact that federal research is grounded in rigorous science."
SOME MEMBERS LINK VACCINES AND AUTISM
Until January's overhaul, major autism groups like the Simons Foundation and Autism Speaks, and researchers from universities including Johns Hopkins and Tufts accounted for most of the committee's 21 members from the public.
That panel recommended further research into co-occurring physical and behavioral health conditions, like epilepsy, gastrointestinal issues and anxiety disorders, according to a draft 2024 report.
David Sitcovsky, vice president of advocacy at Autism Speaks, said in a statement that broader representation would strengthen the committee, but that its impact would depend on retaining a grounding in science.
The new panel contains more activists, just three autistic self-advocates - the minimum required by law - down from seven, and few representatives from research universities. At least eight have tied vaccination to autism or are connected to organizations that support those claims, including several who say their children developed autism after being vaccinated, according to a Reuters review of their public statements and affiliations.
Panel member Ginger Taylor, who created a website called "How Do Vaccines Cause Autism?", wrote in a Substack post that her top priority for the committee is investigating the link between vaccines and autism.
John Gilmore, a new panel member and co-founder of the Autism Action Network who says his 26-year-old son developed autism after being vaccinated, said he wants to steer more research toward rising autism rates.
"A lot of the voices that are on the (committee) now have been deliberately excluded for 20-odd years," he said.
Several, including Gilmore and Fogel, appeared on panels at a September autism event hosted by the MAHA Institute, whose president, Mark Gorton, is an anti-vaccine activist and was a significant funder of Kennedy's 2024 presidential campaign.
Asked how some members' views on vaccines will affect the committee's work, Fogel said studies of the measles-mumps-rubella vaccine and thimerosal-containing vaccines have not shown a causal link to autism.
"That body of available evidence is substantial and must be acknowledged," Fogel said.
Still, research should examine how various exposures, including immune or inflammatory stress, might affect autism outcomes, she said.
EXPERT CONCERNS
On Tuesday, a dozen autism advocates, researchers and several former committee members formed the Independent Autism Coordination Committee to create its own strategic plan for autism research.
Alison Singer, president of the Autism Science Foundation and a prior government committee member, said investing federal dollars into researching a link between vaccines and autism, which most experts consider settled science, would cut into funding for other research opportunities, like autism's heritability or link to environmental exposures.
"There’s not a bottomless pit of money at the NIH that can be used to fund research," Singer said. "If we devote our very limited resources towards reinvestigating vaccines, we won’t have money to look at actual potential causes of autism."
More on the self appointed Independent Autism Coordinating Committee (I-ACC), with a deceitful name and acronym deliberately chosen to confuse the public into thinking that it is the official Interagency Autism Coordinating Committee (I-ACC):
Autism researchers rebuke Kennedy, form independent advisory group
The group wants to be a bulwark against potential misinformation from federal health agencies
By O. Rose Broderick - March 3, 2026A group of autism researchers and advocates announced Tuesday the formation of an independent advisory body that will develop a scientific agenda for the autism community. They hope to act as a bulwark against a federal committee bearing a similar name and its new members who believe that childhood vaccines can cause autism, despite the lack of evidence for such a link.
The Independent Autism Coordinating Committee (I-ACC) will hold its first meeting on March 19 — the same day that the newly-reformed federal body, the Interagency Autism Coordinating Committee (IACC), will meet for its first publicly-announced meeting, as first reported by the Washington Post.
The independent body’s leaders see their group and future actions as a direct rebuke of health secretary Robert F. Kennedy Jr. and his decision to refashion the federal body with members who align with his views on autism and vaccines, instead of preeminent researchers and autistic self-advocates.
“We don’t believe that the new federal IACC is going to pursue the kinds of areas and priorities that the mainstream scientific community feels are important at this point,” said Helen Tager-Flusberg, a member of the new group and director of the Center for Autism Research Excellence at Boston University.
The independent group includes many former members of the federal body, such as Joshua Gordon, former National Institute of Mental Health director, and Alison Singer, president of the Autism Science Foundation. The 12 members are mostly researchers, a contrast with the federal body, whose members mostly focus on advocacy.
Tager-Flusberg says the group will not rehash every matter the federal body considers, but they will primarily determine which topics within autism research deserve the most attention, with an eye on informing the decisions of non-governmental funders. The group will continue to meet whenever the federal body meets in an attempt to halt any misinformation that emerges from the meeting. If, for example, IACC plans to discuss vaccines and autism, the researchers will host a meeting and discuss the existing evidence on the topic on the same day.
When asked whether the similar names, meeting dates, and purported goals could sow confusion in the autism community about who to trust, she responded, “Are you going to pay attention to the group that contains not a single reputable scientist, or anyone experienced with conducting research? Or are you going to look at a group of people, which includes the people who have all the credentials that you would expect from the membership of the IACC?”
The Department of Health and Human Services has no plans to change the federal body’s proceedings in response to their independent counterpart. “The federal IACC will continue to fulfill President Trump’s directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment, and prevention,” said Andrew Nixon, an HHS spokesperson.
This is not the first group of researchers and advocates who have formed their own advisory group as a bid to push back against misinformation from the federal government. The Vaccine Integrity Project launched last year as a means for assessing and disseminating the best available evidence on vaccines.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















